New drug duo targets Tough-to-Treat breast cancer
NCT ID NCT07244874
Summary
This study is testing a new combination of two drugs as a first treatment for people with a specific, hard-to-treat type of advanced breast cancer. It aims to see if the combination is effective and safe for patients whose cancer has spread and cannot be removed by surgery. The trial will enroll about 41 adults who have not yet received treatment for their advanced disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC - TRIPLE-NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.